Article · Wikipedia archive · Last revised Jun 15, 2026

Piperidolate

Piperidolate is a pharmaceutical drug used to treat the symptoms of gastrointestinal disorders including gastric and duodenal ulcers, gastritis, enteritis, gallstones, cholecystitis, and biliary dyskinesia. It acts as an antimuscarinic agent. It was first approved in 1954 and is no longer marketed in the United States.

Last revised
Jun 15, 2026
Read time
≈ 1 min
Length
114 w
Citations
4
Source
Wikipedia ↗
Piperidolate
Clinical data
Trade namesDactil
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
  • 1-Ethylpiperidin-3-yl diphenylacetate
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.001.318
Chemical and physical data
FormulaC21H25NO2
Molar mass323.436 g·mol−1
3D model (JSmol)
  • CCN1CCCC(C1)OC(=O)C(C2=CC=CC=C2)C3=CC=CC=C3
  • InChI=1S/C21H25NO2/c1-2-22-15-9-14-19(16-22)24-21(23)20(17-10-5-3-6-11-17)18-12-7-4-8-13-18/h3-8,10-13,19-20H,2,9,14-16H2,1H3 ☒N
  • Key:KTHVBAZBLKXIHZ-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Piperidolate is a pharmaceutical drug used to treat the symptoms of gastrointestinal disorders including gastric and duodenal ulcers, gastritis, enteritis, gallstones, cholecystitis, and biliary dyskinesia.1 It acts as an antimuscarinic agent.23 It was first approved in 1954 and is no longer marketed in the United States.1

References

References

  1. "Piperidolate". Inxight Drugs. National Center for Advancing Translational Sciences.
  2. "Piperidolate". drugs.com.
  3. Vardanyan R (2017). Piperidine-Based Drug Discovery. Elsevier Science. p. 130. ISBN 978-0-12-813428-3.